歌礼制药(1672.HK)宣布,其双重GLP-1R/GIPR肽激动剂ASC47与ASC31联用,在肥胖动物模型中显示出相

格隆汇
Aug 18

歌礼制药(1672.HK)宣布,其双重GLP-1R/GIPR肽激动剂ASC47与ASC31联用,在肥胖动物模型中显示出相较于ASC47与替尔泊肽联用更为显著的减重效果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10